319 related articles for article (PubMed ID: 19799143)
1. [Epidemiological characteristics and related influencing factors on Japanese encephalitis in Hainan Province].
Pan XH; Sun LY; Wang CL; Zhu J; Fu ZW; Zeng ZC; Zeng XX; Yan XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):471-4. PubMed ID: 19799143
[TBL] [Abstract][Full Text] [Related]
2. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
3. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
4. [Surveillance and control of Japanese encephalitis in Henan province, 1950 - 2008].
Tang XY; Xu BL; Guo WS; Li XL
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):923-6. PubMed ID: 20193229
[TBL] [Abstract][Full Text] [Related]
5. [The prevalence characteristic and prevention strategy of Japanese B Encephalitis in Henan province].
Tang XY; Zhang YP; Xu BL; Li XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Apr; 44(4):329-33. PubMed ID: 20654146
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological situation of Japanese encephalitis in Nepal.
Bista MB; Shrestha JM
JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Japanese encephalitis in South Korea, 2007-2010.
Lee DW; Choe YJ; Kim JH; Song KM; Cho H; Bae GR; Lee JK
Int J Infect Dis; 2012 Jun; 16(6):e448-52. PubMed ID: 22497964
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Japanese encephalitis epidemic in Western Nepal in 1997.
Akiba T; Osaka K; Tang S; Nakayama M; Yamamoto A; Kurane I; Okabe N; Umenai T
Epidemiol Infect; 2001 Feb; 126(1):81-8. PubMed ID: 11293685
[TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.
Yin Z; Beeler Asay GR; Zhang L; Li Y; Zuo S; Hutin YJ; Ning G; Sandhu HS; Cairns L; Luo H;
Vaccine; 2012 Aug; 30(37):5569-77. PubMed ID: 22698453
[TBL] [Abstract][Full Text] [Related]
10. Japanese encephalitis vaccines: moving away from the mouse brain.
Zanin MP; Webster DE; Martin JL; Wesselingh SL
Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
[TBL] [Abstract][Full Text] [Related]
11. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
[TBL] [Abstract][Full Text] [Related]
13. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
14. [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].
Ma FB; Zheng L; Bi C; Tao H; Zhou YL; Zhang JL; Tang FY; Xie P; Zheng CZ; Peng WB; Jiang RJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):113-5. PubMed ID: 12697111
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis: new options for active immunization.
Halstead SB; Thomas SJ
Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
Yu Y
Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
[TBL] [Abstract][Full Text] [Related]
18. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
[TBL] [Abstract][Full Text] [Related]
19. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.
Jia L; Wang Z; Yu Y
Chin Med J (Engl); 2003 Jun; 116(6):941-3. PubMed ID: 12877812
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
